Fulvestrant plus targeted agents versus fulvestrant alone for treatment of hormone-receptor positive advanced breast cancer progressed on previous endocrine therapy: a meta-analysis of randomized controlled trials.
about
Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trialsClinical Safety of Combined Targeted and L. Therapy in Oncological Patients
P2860
Fulvestrant plus targeted agents versus fulvestrant alone for treatment of hormone-receptor positive advanced breast cancer progressed on previous endocrine therapy: a meta-analysis of randomized controlled trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Fulvestrant plus targeted agen ...... randomized controlled trials.
@en
Fulvestrant plus targeted agen ...... randomized controlled trials.
@nl
type
label
Fulvestrant plus targeted agen ...... randomized controlled trials.
@en
Fulvestrant plus targeted agen ...... randomized controlled trials.
@nl
prefLabel
Fulvestrant plus targeted agen ...... randomized controlled trials.
@en
Fulvestrant plus targeted agen ...... randomized controlled trials.
@nl
P2093
P2860
P1433
P1476
Fulvestrant plus targeted agen ...... randomized controlled trials.
@en
P2093
Hong-Biao Wang
Wen-Zhao Lin
Xu-Yuan Li
P2860
P2888
P304
P356
10.1007/S12282-017-0770-3
P577
2017-03-21T00:00:00Z